Persistent Alopecia Leads to Taxotears

“It’s just hair” and “it will grow back.” How many times have those statements been offered up to women who will undergo chemotherapy? Intended or not, they are dodging at best, dismissing at worst a woman’s valid emotions at having to surrender her hair in the name of life. OF COURSE it’s a small price to pay for survival (who doesn’t know that!?), but a price no less. As women facing cancer treatment, we set our eyes on the prize, that being a future that includes life, love, health…. AND the return of our hair.

But what if they’re wrong? Or more accurately asked, what if there is a 3-6 percent chance our hair loss will persist for years following chemotherapy or possibly even for the rest of our lives? Responding to the growing number of women who take Taxotere with other chemotherapy drugs and find their hair does not grow back, Vice President of Medical Affairs for the pharmaceutical gargantuan, Sanofi-Aventis responds:

“Taking into account the benefit brought by this type of therapy, we think things should be put in perspective.”

Ok, but whose perspective? That of the profiteers, or that of the sufferers?

Persistent alopecia is in fact potential side effect of the chemotherapy drug Taxotere when taken in combination with other drugs. There is even a support and advocacy group of women who suffer persistent alopecia due to Taxotere who call themselves “Taxotears.” Their objective is not to get Taxotere taken off the market but to ensure that each and every woman who is offered Taxotere as a chemotherapy regimen be warned that persistent alopecia is a possibility. They simply want women to have the ability to make their own informed choice.

Finding the new “normal” as a cancer survivor is hard enough even when our hair does grow back. We deserve the right to make informed choices. It’s not just about our hair, it’s about our ability to heal and re-identify with the cancer-free version of ourselves.

Have you or anyone you know taken Taxotere and experienced persistent alopecia? If you’ve ever taken Taxotere, were you told beforehand that persistent alopecia was a potential side effect?

Susan Beausang, 4Women.com

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap